Table 2.
Days after injury | Phe | Ang II | BK | |||
---|---|---|---|---|---|---|
Contralateral | Ipsilateral | Contralateral | Ipsilateral | Contralateral | Ipsilateral | |
Control | 8.64±0.20 | 9.12±0.13 | 6.61±0.50 | |||
2 | 8.72±0.30 | 8.13±0.19 | 8.76±0.16 | 9.08±0.18 | 6.45±0.14 | ND |
4 | 8.26±0.10 | 8.50±0.53 | 9.45±0.25 | 8.92±0.12 | 6.23±0.33 | 6.97±0.18 |
7 | 8.09±0.19 | 7.83±0.40 | 9.03±0.33 | 8.74±0.25 | 6.08±0.17 | 6.85±0.20 |
15 | 8.33±0.19 | 8.20±0.14 | 8.66±0.12 | 9.10±0.27 | 6.45±0.18 | 7.41±0.13 |
30 | 8.39±0.27 | 7.89±0.32 | 8.91±0.16 | 8.32±0.17 | 6.06±0.12 | 6.16±0.41 |
45 | 8.12±0.17 | 8.11±0.37 | 8.88±0.13 | 8.63±0.19 | 6.21±0.28 | 6.73±0.13 |
ANOVA: not significant. ND: not determined.